Title: Influenza Vaccination Among Asthmatic Patients During the
1Influenza Vaccination Among Asthmatic Patients
Duringthe Flu Season
- Jalal Zuberi, Nabila Haque, Mary Hixson,
- Sonja Hutchins
2Background
- Asthma a substantial health problem
- 15 million Americans
- 5 million lt18 years
- Advisory groups recommend influenza
- vaccine for asthmatic patients
- High national health objectives for 2010
- (60-90)
3Influenza Vaccine Coverage in Asthmatic Patients
Author(Year) Study Design Population Coverage
Kramarz (1995-1997) Cohort 68,839 lt18 yrs 9-10
Chung (1998) Cross-sectional 117 6-48 mos 25
Rangel (1998) Cross-sectional 2,000 18-64 yrs gt65yrs 32 63
4Influenza Vaccine Safetyin Asthmatic Patients
Author(Year) Study Design Population Difference
ALA (2000) RCT 2032 1-6 yrs 1.1 NS
Kramarz (1993-1996) Cohort 70,753 lt18 yrs 0.65-0.78
Cates (lt2000) 5 RT Variable Variable
Nicholson (1998) RCT 262 18-75 yrs NS
IRR
5Objectives
- Assess influenza vaccine coverage among asthmatic
patients in an academic medical practice - Identify factors that predict influenza
vaccination
6MethodsStudy Design
- Retrospective cohort study
- 1997-1998 influenza season
- Medical record review, 1999-2000
- Information from record
- Date of birth Insurance
- Gender Asthma severity
- Race/ethnicity Influenza vaccine
7Methods-Study Population
- Computerized billing list of patients with ICD- 9
code 493 for asthma - Visit between September 1, 1997
- April 30, 1998
- No other chronic diseases
- No allergic reactions to vaccination
8MethodsAsthma Severity
- Symptoms Nocturnal PEF
- Mild gt1/week, gt2/month gt80
- lt1/day
- Moderate Daily gt1/week 60-80
- Severe Continual Frequent lt60
9Study Population-Age DistributionN216
Age (Years) Number Percent
lt5 37 17
5-17 71 33
18-64 93 43
gt65 14 7
10Study Population Gender and and Race/Ethnicity
Gender Number Percent()
Female 126 59
Male 88 41
Race/Ethnicity
African American 78 96
White American 2 4
11Study Population--Insurance Status
Insurance Number Percent
Private 124 57
Public 81 38
Other(Military) 1 0.5
None 10 5
12Study PopulationAsthma Severity
Age (Years) Number Percent
Mild 54 26
Mild-Moderate 20 10
Moderate 32 16
Moderate-Severe 24 12
Severe 22 11
Unclassified 54 26
13Influenza Vaccine Coverage of Asthma Patients in
1997-1998 and 2010 National Health Objectives
(N216)
90
60
31
14Influenza Vaccine Coverage in Asthma Patients By
Age Group, 1997-1998
National Health Objective (gt65yrs), 2000
15Predictors of Influenza Vaccination
16Predictor of Influenza Vaccination in Asthma
Patients-Age
Age Total Vaccinated RR (95CI)
lt17 yrs 108 12 Reference
gt18 yrs 107 49 4.0(2.3-7.0)
17Predictor of Influenza Vaccination in Asthma
Patients-Gender
Gender Total Vaccinated RR (95CI)
Female 126 36 1.5(1.0-2.3)
Male 88 24 Reference
18Predictor of Influenza Vaccination in Asthma
Patients-Race/Ethnicity
Ethnicity Total Vaccinated RR (95CI)
African American 78 32 Reference
White American 2 100 3.1(2.3-4.3)
Fishers Exact, P0.11
19Predictor of Influenza Vaccination in Asthma
Patients-Insurance Status
Insurance Total Vaccinated RR(95CI)
Private 124 23 Undefined
Public 81 46 Undefined
None/Other 11 0 Reference
Fishers Exact P lt0.01 and P0.12
20Predictor of Influenza Vaccination in Asthma
Patients--Severity of Asthma
13.1
5.6
4.5
1.0
0.9
NumberRR Plt0.05
21Preliminary ResultsFollow-Up Study2000-2001
Influenza Season
22Influenza Vaccine Coverage in Asthma Patients By
Season
National Vaccine Shortage
66/216
6/121
23Patient Reported Reasons For Lack of Vaccination
(N113)
Reason Number Percent
Doctor did not advise 73 65
Safety concern 21 16
Vaccine not effective 5 4
Not convenient 5 4
Did not get around to it 4 4
No need for vaccine 2 2
Sick at visit 2 2
Afraid of needles 1 1
Did not know 1 1
24Conclusions
- Suboptimal influenza vaccine coverage
- Coverage improved with age and severity
- of asthma
- Predictors of vaccination
- Adults
- Female
- Insurance
- Moderate/severe asthma
-
25Conclusion (Continued)
- Substantial drop in vaccine coverage during
national vaccine shortage - No doctor advice--most frequent reason for
- lack of vaccination
- Comprehensive follow-up study underway to
- Compare various providers (specialty and county
hospital outpatient department) - Use findings as baseline for intervention study
26(No Transcript)